Prospects for expanding the use of β-lactamase inhibitors

References

1. Thomson C. J., Hood J., Miles R. S., Amyes S. G. B. Prevalence of the TEM-1 β-lactamase in urinary E. coli: continued efficacy of amoxycillin plus clavulanic acid. Abstracts of the 1st International Congress on the Management of Infection No. Pl.21 199273
2. Seetulsingh P. S., Hall L. M. C., Livermore D. M. Activity of cla-vulanate combinations against TEM-1 β-lactamase producing Escherichia coli isolates obtained in 1982 and 1989. J Antimicrob Chemother 1991; 27:749–759
   [Google Scholar]
3. Rolinson G. N. Evolution of β-lactamase inhibitors. Rev Infect Dis 1991; 13: Suppl 9S727–S732
   [Google Scholar]
4. Philippon A., Labia R., Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33:1131–1136
   [Google Scholar]
5. Wiedemann B., Kliebe C., Kresken M. The epidemiology of β-lactamases. J Antimicrob Chemother 1989; 24: Suppl B1–22
   [Google Scholar]
6. Payne D. J., Amyes S. G. B. Transferable resistance to extended spectrum β-lactams: a major threat of a minor inconvenience?. J Antimicrob Chemother 1991; 27:255–261
   [Google Scholar]
7. Sirot J., Chanal C., Petit A., Sirot D., Labia R., Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiological studies. Rev Infect Dis 1988; 10:850–859
   [Google Scholar]
8. Payne D. J., Cramp R. Determination of ID₅₀ values for 35 plasmid mediated β-lactamases. Abstracts of the 1st International Congress on the Management of Infection No. 10B.7 199265
9. Jarlier V., Nicolas M. H., Fournier G., Philippon A. Extended broad spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867–878
   [Google Scholar]
10. Payne D. J., Woodford N., Amyes S. G. B. Characterization of the plasmidβ-lactamase BIL-1. J Antimicrob Chemother 1992; 30:119–127
    [Google Scholar]
11. Papanicolaou G. A., Medeiros A. A., Jacoby G. A. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino-and-mthoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990; 34:2200–2209
    [Google Scholar]
12. Rubio M. C., Gil J., Castillo J. The susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital. J Antimicrob Chemother 1989; 24: Suppl B35–40
    [Google Scholar]
13. Sanders C. C., Iaconis J. P., Bodey G. P., Samonis G. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: Role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988; 32:1365–1369
    [Google Scholar]
14. French G., Ling J. Amoxycillin/clavulanate resistant Escheric hia coli. Lancet 1988; 1:704
    [Google Scholar]
15. Shannon K., Williams H., King A., Phillips I. Hyperproduction of TEM-1 β-lactamase in clinical isolates of Escherichia coli serotype O15. FEMS Microbiol Lett 1990; 55:319–323
    [Google Scholar]
16. Martinez J. L., Vicente M. F., Delgado-Iribarren A., Perez-Diaz J. C., Baquero F. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother 1989; 33:595
    [Google Scholar]
17. Page J. W. J., Farmer T. H., Elson S. W. Hyperproduction of TEM-1 β-lactamase by Escherichia coli strains. J Antimicrob Chemother 1989; 23:160–161
    [Google Scholar]
18. Thomson C. J., Amyes S. G. B. TRC-1: Emergence of a clavulanic acid-resistant TEM /?-lactamase in a clinical strain. FEMS Microbiol Lett 1992; 91:113–118
    [Google Scholar]
19. Belaaouaj A., Lapoumeroulie C., Vedel G., Nevot P., Krishnamoorthy R., Paul G. Amino acid 241 of TEM-1 is highly critical in conferring resistance to ampicillin-clavulanic acid combination: molecular characterisation of a natural mutant. Abstracts of the 31st I.C.A.A.C. No. 944 1991256
20. Manavathu E. K., Lemer S. A., Fekete T., Perlin M. H., Ziaja E., Price S. Characterization of mutant TEM β-lactamase that confers resistance to ampicillin (amp) plus clavulanic acid (CA). Abstracts of the 30th I.C.A.A.C. No. 281 1990133